Atlas Trials

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

Clinical trial NCT00122577 · TERMINATED

Trial details

NCT number
NCT00122577
Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2002-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.